Mr Chris Nam
Higher Degree by Research Candidate
School of Medicine
College of Health
Eunwoo (Chris) Nam is a PhD candidate at the Centre for Cancer Biology, an alliance between Adelaide University and SA Pathology, in Adelaide, South Australia, Australia. For his PhD project, Chris works on investigating various ways to improve the efficacy of GD2 chimeric antigen receptor (CAR)-T cells against glioblastoma.
| Year | Citation |
|---|---|
| 2026 | Gardam, B., Gargett, T., Nam, E., Khan, S., Ormsby, R. J., Poonnoose, S. I., . . . Ebert, L. M. (2026). Tumors Located in the Brain Impair the Frequency and Phenotype of Dendritic Cells in Blood and Tumor.. iScience, 29(3), 115160. Scopus1 WoS1 Europe PMC1 |
| 2026 | Gardam, B., Nam, E., Kollis, P. M., Kilyen‐Coles, J., Lenin, S., Gliddon, B. L., . . . Gargett, T. (2026). A characterisation of the immune cells in immunocompetent and immunodeficient mice with orthotopic brain tumors. Clinical & Translational Immunology, 15(4), 19 pages. |
| 2024 | Lin, M. Y., Nam, E., Shih, R. M., Shafer, A., Bouren, A., Ceja, M. A., . . . Chen, Y. Y. (2024). Self-regulating CAR-T cells modulate cytokine release syndrome in adoptive T-cell therapy. Journal of Experimental Medicine, 221(6), 28 pages. Scopus30 WoS29 Europe PMC26 |
| 2020 | Zah, E., Nam, E., Bhuvan, V., Tran, U., Ji, B. Y., Gosliner, S. B., . . . Chen, Y. Y. (2020). Systematically optimized BCMA/CS1 bispecific CAR-T cells robustly control heterogeneous multiple myeloma. Nature Communications, 11(1), 13 pages. Scopus190 WoS177 Europe PMC155 |
| 2017 | Li, S., Nih, L. R., Bachman, H., Fei, P., Li, Y., Nam, E., . . . Segura, T. (2017). Hydrogels with precisely controlled integrin activation dictate vascular patterning and permeability. Nature Materials, 16(9), 953-961. Scopus183 WoS170 Europe PMC142 |
Connect With Me
External Profiles
